System for evaluating urine for the presence or absence of pregnanediol glucuronide and other hormones and analytes
AssigneeMFB Fertility, Inc.
InventorAmy BECKLEY
Life of this patent
Estimating the term…
Abstract
Embodiments of the invention comprise a test strip configured to detect one or more metabolites of progesterone in urine, and optionally further detect one or more additional metabolites or hormones in urine within the same test strip. Embodiments of the invention are methods of utilizing such a test strip in association with avoidance of pregnancy, detection of menopause, and in association with fertility planning purposes. Embodiments of the invention are associated with the incorporation of a test strip within a testing kit, optionally further comprising a digital reader.
Claims17
1-20. (canceled)
A fertility tracking system for evaluating a menstrual cycle, comprising:
- a lateral flow assay configured to evaluate for the presence or absence of hormones or hormonal analytes within a fluid sample placed into contact with the lateral flow assay, wherein the hormones or hormonal analytes comprise pregnanediol glucuronide, luteinizing hormone, and estrogen or a metabolite of estrogen,
- wherein, for each hormone or hormonal analyte, the lateral flow assay comprises a label configured to visually indicate the presence or absence of the hormone or hormonal analyte in a result indication line;
- an optical reader configured to provide a wavelength of light selected based on the excitation wavelength of the label for each hormone or hormonal analyte, and illuminate the result indication line for each hormone or hormonal analyte that provides indication for the presence or absence of the hormone or hormonal analyte.
Dependencies are inferred from the claim text.